The survival rate of advanced liver cancer is very low. From the global data, the number of new liver cancer cases is now about 850,000 per year, and 780,000 died in the same year, which is relatively equal, that is to say, the difference between those who developed the disease and those who died in the same year is not much. According to clinical experience combined with data from other medical centers, the five-year survival rate after radical resection of small, early-stage and subclinical hepatocellular carcinoma is about 60%. The standard of liver cancer cure in our country is different from other countries, Japan takes ten years as an example, we take five years as a watershed. Ten years ago, more than 90% of liver cancer patients were walking in and lying down during surgery. Now, with the progress of basic medicine, medical devices and other life science research, the comprehensive treatment of liver cancer is greatly improved than before.